{"disease":{"id":"meningitis-meningococcal","name":"meningitis meningococcal"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04664569","title":"National Bacterial Meningitis Study","phase":"","overall_status":"RECRUITING","enrollment_count":8230,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT02842853","title":"Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3344,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02199691","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1715,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03433482","title":"A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1707,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03378258","title":"Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.","phase":"","overall_status":"COMPLETED","enrollment_count":1329,"lead_sponsor_name":"Belfast Health and Social Care Trust","has_results":false},{"nct_id":"NCT02864927","title":"Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1311,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT04707391","title":"Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1250,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05252715","title":"Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1200,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT03205371","title":"Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1183,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03493919","title":"A Sourcing Study to Collect Human Blood Samples From Healthy Adults","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1021,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03077438","title":"Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02955797","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":918,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02842866","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":907,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02752906","title":"Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":810,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT05229536","title":"Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT01049035","title":"A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03587207","title":"Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":520,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03295318","title":"Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"Serum Institute of India Pvt. Ltd.","has_results":true},{"nct_id":"NCT05087056","title":"Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":312,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01732627","title":"Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02724046","title":"Ciprofloxacin for the Prevention of Meningococcal Meningitis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Epicentre","has_results":false},{"nct_id":"NCT01890759","title":"Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT00443846","title":"RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03824093","title":"High and Low Resource Interventions to Promote HPV Vaccines","phase":"NA","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"Children's Mercy Hospital Kansas City","has_results":false},{"nct_id":"NCT02640404","title":"Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03205358","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02591290","title":"Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04665791","title":"A Human Controlled Infection Study with Neisseria Lactamica in Malian Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Center for Vaccine Development - Mali","has_results":false},{"nct_id":"NCT06113198","title":"A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":50,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT04685850","title":"Long-term Sequelae of Childhood Meningitis and Meningococcal Purpura Fulminans","phase":"","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Centre Hospitalier Intercommunal Creteil","has_results":false},{"nct_id":"NCT03549325","title":"A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14","phase":"NA","overall_status":"TERMINATED","enrollment_count":21,"lead_sponsor_name":"University Hospital Southampton NHS Foundation Trust","has_results":true},{"nct_id":"NCT03431675","title":"Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Epicentre","has_results":false}],"total":32},"guidelines":[],"source":"Drug Landscape verified database"}